Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 3/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.54 |
| ▸ | HTT | P42858 | 2/20 | 0.54 |
| ▸ | MAPT | P10636 | 2/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.54 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.54 |
| ▸ | NPC1 | O15118 | 3/20 | 0.48 |
| ▸ | GAA | P10253 | 1/20 | 0.45 |
| ▸ | SLC16A3 | O15427 | 1/20 | 0.44 |
| ▸ | PLK1 | P53350 | 10/20 | 0.43 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.43 |
| ▸ | PLK3 | Q9H4B4 | 2/20 | 0.42 |
| ▸ | RAB9A | P51151 | 2/20 | 0.42 |
| ▸ | GFER | P55789 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24379797 | 0.89 | EP300 (0.53) | MEN1KMT2AHTTMAPTALDH1A1 | |
| SCHEMBL20787640 | 0.87 | NPC1 (0.49) | MEN1KMT2AHTTMAPTALDH1A1 | |
| SCHEMBL16371053 | 0.85 | MAPT (0.41) | MEN1KMT2AHTTMAPTALDH1A1 | |
| SCHEMBL17775442 | 0.84 | ALDH1A1 (0.47) | MEN1KMT2AHTTMAPTALDH1A1 | |
| SCHEMBL20787628 | 0.83 | MEN1 (0.41) | MEN1KMT2AHTTMAPTALDH1A1 | |
| SCHEMBL20786981 | 0.83 | MITF (0.42) | MEN1KMT2AHTTMAPTALDH1A1 | |
| SCHEMBL20787386 | 0.82 | ALDH1A1 (0.38) | MEN1KMT2AHTTMAPTALDH1A1 | |
| SCHEMBL26543681 | 0.81 | PLG (0.38) | MEN1KMT2AHTTMAPTALDH1A1 | |
| SCHEMBL16392463 | 0.79 | EP300 (0.57) | MEN1KMT2AGAARAB9A | |
| SCHEMBL26544999 | 0.79 | PLG (0.37) | MEN1KMT2AHTTMAPTALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11319279-B2 | Antimicrobial compound and use thereof | KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (KR) | 2022-05-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11319279-B2 | Antimicrobial compound and use thereof | AAAS, VRK1, CACNA1E | MEN1 3577/4885KMT2A 2077/4885HTT 2936/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.